Cargando…
Post-VX exposure treatment of rats with engineered phosphotriesterases
The biologically stable and highly toxic organophosphorus nerve agent (OP) VX poses a major health threat. Standard medical therapy, consisting of reactivators and competitive muscarinic receptor antagonists, is insufficient. Recently, two engineered mutants of the Brevundimonas diminuta phosphotrie...
Autores principales: | Stigler, Lisa, Köhler, Anja, Koller, Marianne, Job, Laura, Escher, Benjamin, Potschka, Heidrun, Thiermann, Horst, Skerra, Arne, Worek, Franz, Wille, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837561/ https://www.ncbi.nlm.nih.gov/pubmed/34962578 http://dx.doi.org/10.1007/s00204-021-03199-6 |
Ejemplares similares
-
Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro
por: Köhler, Anja, et al.
Publicado: (2021) -
Evidence of nerve agent VX exposure in rat plasma by detection of albumin-adducts in vitro and in vivo
por: Kranawetvogl, Tamara, et al.
Publicado: (2023) -
In Vitro Interaction of Organophosphono- and Organophosphorothioates with Human Acetylcholinesterase
por: Worek, Franz, et al.
Publicado: (2020) -
Organophosphorus compounds and oximes: a critical review
por: Worek, Franz, et al.
Publicado: (2020) -
Isolation of human TRPA1 channel from transfected HEK293 cells and identification of alkylation sites after sulfur mustard exposure
por: Müller-Dott, Katharina, et al.
Publicado: (2022)